Raffaella Ravinetto

Biographic Data

ID2315345
NAMERaffaella Ravinetto
GIVEN NAMESRaffaella
FAMILY NAMERavinetto
SIGNATURERAVINETTO R
AFFILIATIONSInstituut voor Tropische Geneeskunde
ORCID0000-0001-7765-2443
VERIFIEDYes
TOTAL WORKS26
TOTAL CITATIONS1
AUTHOR COUNT26
EDITOR COUNT0
FIRST PUBLICATION YEAR2015
LATEST PUBLICATION YEAR2026
H-INDEX1

  • Systemic challenges in the supply and distribution of medicines in conflict-affected areas of Mali

    Open AccessMohamed Ali Ag Ahmed, Mama Konta et al.ARTICLEGlobal Health Action2026

    BACKGROUND: The conflicts that have been ongoing for over a decade in different Sahel countries, including Mali, have a negative impact on the supply and distribution of medicines. OBJECTIVE: This study aims to identify and analyze the key contextual challenges affecting the supply and distribution of medicines in conflict-affected areas in Mali. METHODS: This study adopts a qualitative study design. First, we conducted 28 interviews with key sta…

  • Can a code of professional ethics influence the supply of substandard and falsified medicines? Insights from Ethiopia

    Open AccessAkalework Mengesha, Robert Dingwall et al.ARTICLECritical Public Health2026

    Substandard and falsified (SF) medicines are serious global health problems. Their high prevalence is a threat to public health in resource-limited settings. It is assumed that professionals will uphold specific standards of behaviour to protect the public interest and maintain trust. This study assesses whether a professional ethical code can serve as an effective way to prevent and respond to SF medicines by enhancing ethical behaviours in prac…

  • Inadequate last-mile pharmaceutical waste management is a neglected threat to environmental and public health

    Open AccessRaffaella Ravinetto, Jennie Lates et al.ARTICLEBMJ Global Health2025

    BOX Last-mile pharmaceutical waste is generated at the level of the community, healthcare facilities, pharmaceutical outlets and markets, and animal husbandry

  • Is global health security worth 0.01% of our gross domestic product

    Open AccessGorik Ooms, Yibeltal Assefa et al.ARTICLEPLOS Global Public Health2025

  • Contextual constraints and dilemmas influencing health providers’ prescription practices in a conflict-affected area

    Open AccessIssa Coulibaly, Yacouba Diarra et al.ARTICLEPLOS Global Public Health2025

    Armed conflicts present complex, multidimensional challenges that severely compromise both access to and the quality of healthcare, including the adequate prescription of essential medicines. This study aimed to identify and understand the factors underlying the irrational prescribing of medicine in areas affected by armed conflict in the Mopti region in Mali. An exploratory qualitative study was conducted using a semi-structured interview guide …

  • Access to essential medicines for noncommunicable diseases during conflicts

    Open AccessSaleh Aljadeeah, Belen Tarrafeta et al.ARTICLEPLOS Global Public Health2025

    Access to essential medicines is a critical component of healthcare. Conflicts severely disrupt pharmaceutical supply chains. This study examines the availability and prices of essential noncommunicable diseases (NCDs) medicines in Northern Syria, and explores the underlying factors contributing to medicine shortages and price variability. We applied a mixed-methods approach, combining a cross-sectional quantitative survey based on the World Heal…

  • Assessing patterns of authorship of low- and middle-income countries in global commercial clinical trials in oncology

    Open AccessAnil Babu Payedimarri, Samir Mouhssine et al.ARTICLEGlobalization and Health2025

    Poor authorship practices in global health research may be a sign of unequal partnerships. Previous studies have shown that authors from low- and middle-income countries (LMICs) are frequently underrepresented in publications from global research collaborations between LMICs and high-income countries (HICs). To the best of our knowledge, the patterns of authorship from LMICs in international industry-sponsored clinical research on breast, lung an…

  • Irrational medicine use and its associated factors in conflict-affected areas in Mali

    Open AccessMohamed Ali Ag Ahmed, Alassane Seydou et al.ARTICLEGlobal Health Action2025

    BACKGROUND: Rational use of essential medicines is a critical step towards prevention and treatment of many illnesses. However, it represents a significant challenge worldwide, and particularly for under-resourced health systems in conflict-affected areas. OBJECTIVE: To assess barriers to rational use of essential medicines at primary healthcare level in conflict-affected areas of Mali. METHODS: We conducted a cross-sectional study in twenty rand…

  • Dispensing of medicines for asthma and chronic obstructive pulmonary disease through the government health insurance in Syria

    Open AccessSaleh Aljadeeah, Raffaella Ravinetto et al.ARTICLEGlobal Health Action2025

    BACKGROUND: Asthma and chronic obstructive pulmonary disease (COPD) are common noncommunicable diseases, exacerbated in conflict settings by the heightened environmental exposure to triggers, weakened health systems, and poor access to medicines and healthcare. However, accurate data on medicines dispensing in this context are generally scarce. OBJECTIVE: We examined the patterns and rates of medicines dispensing for asthma and COPD among the ben…

  • Can Systemic Corruption be Prevented by Legal Means? The Market for Pharmaceuticals in Southern Ethiopia

    Akalework Mengesha, Hilde Bastiaens et al.ARTICLEPublic Integrity2025References: 29

    Some international and national regulatory and policy actors assume thatstrengthening domestic laws and tightening enforcement measures will besufficient to reduce the extra-legal supply of medicines, whether legal, sub-standard, or falsified, to patients in low- and middle-income countries. Thispaper uses a qualitative study of the pharmaceutical market in SouthernEthiopia to argue that this assumption is unjustified, given the commonlack of ins…

  • An ancillary care policy in a vaccine trial conducted in a resource-constrained setting

    Open AccessGwen Lemey, Ynke Larivière et al.ARTICLEBMJ Global Health2024

    INTRODUCTION: Clear guidelines to implement ancillary care (AC) in clinical trials conducted in resource-constrained settings are lacking. Here, we evaluate an AC policy developed for a vaccine trial in the Democratic Republic of the Congo and formulate policy recommendations. METHODS: To evaluate the AC policy, we performed a longitudinal cohort study, nested in an open-label, single-centre, randomised Ebola vaccine trial conducted among healthc…

  • Access to medicines among asylum seekers, refugees and undocumented migrants across the migratory cycle in Europe

    Open AccessSaleh Aljadeeah, Anil Babu Payedimarri et al.ARTICLEBMJ Global Health2024

    INTRODUCTION: Access to essential medicines is a critical element of health systems and an important measure of their performance. Migrants may face barriers in accessing healthcare, including essential medicines, throughout the migration cycle, which includes the stages of departure from home or residence countries, transit through non-European or European countries, reception and settlement in a country in Europe and deportation. We aim to prov…

  • Shaping the future of global access to safe, effective, appropriate and quality health products

    Open AccessRaffaella Ravinetto, RODRIGO HENRÍQUEZ et al.ARTICLEBMJ Global Health2024

    status: Published

  • Researchers’ responsibilities in resource-constrained settings

    Open AccessGwen Lemey, Trésor Zola et al.ARTICLEResearch Ethics2024

    In this paper, we discuss challenges associated with implementing a policy for Ancillary Care (AC) for related and unrelated (serious) adverse events during an Ebola vaccine trial conducted in a remote area of the Democratic Republic of the Congo. Conducting clinical trials in resourceconstrained settings can raise context-related challenges that have implications for study participants’ health and wellbeing. During the Ebola vaccine study, three…

  • Research ethics preparedness during outbreaks and public health emergencies

    Open AccessRaffaella Ravinetto, Joyce Adhiambo et al.ARTICLEResearch Ethics2024

    Research represents an essential component of the response to infectious disease outbreaks and to other public health emergencies, whether they are localised, of international concern, or global. Research conducted in such contexts also comes with particular ethics challenges, the awareness of which has significantly grown following the Ebola outbreak in West Africa, the Zika outbreak in Latin America and the COVID-19 pandemic. These challenges i…

  • Substandard and falsified medicines in African pharmaceutical markets

    Open AccessAkalework Mengesha, Hilde Bastiaens et al.ARTICLESocial Science & Medicine2024Cited by: 1References: 16

  • Uncertainties about the quality of medical products globally

    Open AccessPatricia Kingori, Koen Peeters Grietens et al.ARTICLEBMJ Global Health2023

  • How the concept of WHO-listed authorities will change international procurement policies for medicines

    Open AccessCécile Macé, Lembit Rägo et al.ARTICLEBMJ Global Health2022

  • Facilitating access to medicines and continuity of care for Ukrainian refugees

    Open AccessSaleh Aljadeeah, Joris Michielsen et al.ARTICLEBMJ Global Health2022

    Aljadeeah S, Michielsen J, Ravinetto R, et al. Facilitating access to medicines and continuity of care for Ukrainian refugees: exceptional response or the promise of more inclusive healthcare for all migrants? BMJ Global Health . 2022;7(8): e010327

  • Algorithm for the support of non-related (serious) adverse events in an Ebola vaccine trial in the Democratic Republic of the Congo

    Open AccessGwen Lemey, Ynke Larivière et al.ARTICLEBMJ Global Health2021

    Implementing an Ebola vaccine trial in a remote area in the Democratic Republic of the Congo (DRC), and being confronted with a dysfunctional health care system and acute unmet health needs of participants, ethical considerations were made regarding the ancillary care obligations of the sponsor and researchers. Spurred by the occurrence of non-related (serious) adverse events (NR-SAEs), the Universities of Antwerp and Kinshasa jointly developed a…

  • Vaccinating children in high-endemic rabies regions

    Open AccessPatrick Soentjens, Nicole Berens-Riha et al.ARTICLEBMJ Global Health2021

    box On September 28 this year, the World Rabies Day came as a reminder that a fully preventable viral encephalitis still claims at least 59 000 victims per year in over 150 countries; and particularly in rural Africa and Asia, where over 40% of individuals bitten by a suspect rabid animal are children. Sadly, these figures are probably underestimated.1 Rabies is one of the Neglected Tropical Diseases (NTDs) announced by the WHO, that is, a divers…

  • Europe should lead in coordinated procurement of quality-assured medicines for programmes in low-income and middle-income countries

    Open AccessChristophe Perrin, Sandrine Cloez et al.ARTICLEBMJ Global Health2020

    box A secured supply of quality-assured medicines and other medical products is an essential prerequisite for universal health coverage. Unfortunately, on average one in 10 medicines do not meet acceptable quality standards in low-income and middle-income countries (LMICs).1 2 The high prevalence of poor-quality medicines in LMICs greatly depends on the globalisation of pharmaceutical production and distribution, combined with the weakness of man…

  • Informed consent, community engagement, and study participation at a research site in Kigali, Rwanda

    Open AccessJennifer I Van Nuil, Evelyne Kestelyn et al.ARTICLEDeveloping World Bioethics2018

    People enroll in medical research for many reasons ranging from decisions regarding their own or family members' health situation to broader considerations including access to health and financial resources. In socially vulnerable communities the choice to participate is often based on a risk‐benefit assessment that goes beyond the medical aspects of the research, and considers the benefits received. In this qualitative study, we examined the mot…

  • Community sensitization and decision‐making for trial participation

    Open AccessSusan Dierickx, Arghya Bandopadhyay et al.ARTICLEDeveloping World Bioethics2018

    Community sensitization is effective in providing first-hand, reliable information to communities as the information is cascaded to those who could not attend the sessions. However, further research is needed to assess how the informal spread of information further shapes people's expectations, how the process engages with existing social relations and hierarchies (e.g. local political power structures; permissions of heads of households) and how…

  • The Challenges of Research Informed Consent in Socio‐Economically Vulnerable Populations

    Open AccessMarion Kalabuanga, Raffaella Ravinetto et al.ARTICLEDeveloping World Bioethics2016

    In medical research, the ethical principle of respect for persons is operationalized into the process of informed consent. The consent tools should be contextualized and adapted to the different socio‐cultural environment, especially when research crosses the traditional boundaries and reaches poor communities. We look at the challenges experienced in the malaria Quinact trial, conducted in the D emocratic R epublic of C ongo, and describe some l…